Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

1. Larson, R.A.
2. Sievers, E.L.
3. Stadtmauer, E.A.
4. Löwenberg, B.
5. Estey, E.H.
6. Dombret, H.
7. Theobald, M.
8. Voliotis, D.
9. Bennett, J.M.
10. Richte, M.
11. Leopold, L.H.
12. Berger, M.S.
13. Sherman, M.L.
14. Loken, M.R.
15. Van Dongen, J.J.M.
16. Bernstein, I.D.
17. Appelbaum, F.R.